| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
|
18,020 |
15,898 |
$2.22M |
| 99283 |
|
27,426 |
24,529 |
$1.89M |
| 74177 |
|
4,711 |
4,025 |
$1.76M |
| 99282 |
|
18,779 |
17,221 |
$1.11M |
| 70450 |
|
4,976 |
4,281 |
$870K |
| 99285 |
|
4,702 |
3,969 |
$843K |
| 99213 |
|
38,536 |
34,796 |
$824K |
| 99214 |
|
21,683 |
19,058 |
$682K |
| 80307 |
|
14,048 |
11,570 |
$599K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,161 |
5,525 |
$495K |
| 96361 |
|
4,645 |
3,874 |
$486K |
| 0202U |
|
3,763 |
3,354 |
$439K |
| 87428 |
|
4,548 |
4,084 |
$321K |
| 71045 |
|
17,315 |
14,935 |
$313K |
| 87804 |
|
24,408 |
13,343 |
$304K |
| 87426 |
|
6,446 |
5,829 |
$256K |
| 80053 |
|
38,435 |
33,362 |
$229K |
| 93005 |
|
19,459 |
16,215 |
$210K |
| 85025 |
|
39,129 |
33,320 |
$184K |
| 87880 |
|
12,371 |
11,492 |
$173K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
9,073 |
7,847 |
$170K |
| 96374 |
|
11,271 |
9,998 |
$158K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
1,336 |
1,086 |
$137K |
| 74176 |
|
710 |
585 |
$130K |
| 96375 |
|
4,930 |
4,189 |
$97K |
| 87591 |
|
3,679 |
3,237 |
$83K |
| 87491 |
|
3,562 |
3,229 |
$78K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
15,628 |
11,452 |
$78K |
| 71275 |
|
450 |
384 |
$75K |
| 84484 |
|
16,285 |
12,342 |
$73K |
| 71046 |
|
1,961 |
1,769 |
$57K |
| 87081 |
|
7,672 |
7,194 |
$53K |
| 81001 |
|
24,342 |
21,034 |
$53K |
| 83690 |
|
12,066 |
10,508 |
$52K |
| J3490 |
Unclassified drugs |
21,108 |
8,077 |
$50K |
| 96365 |
|
991 |
843 |
$47K |
| 36415 |
|
33,841 |
28,390 |
$45K |
| 84443 |
|
5,879 |
5,158 |
$44K |
| 82550 |
|
15,217 |
12,170 |
$44K |
| 96372 |
|
4,887 |
3,785 |
$41K |
| 82553 |
|
8,750 |
6,998 |
$40K |
| 36000 |
|
3,721 |
3,265 |
$35K |
| 90471 |
|
2,494 |
2,377 |
$34K |
| 87635 |
|
1,356 |
1,230 |
$34K |
| 87086 |
|
7,152 |
6,192 |
$32K |
| 96360 |
|
360 |
324 |
$29K |
| 0241U |
|
227 |
215 |
$27K |
| 80061 |
|
2,762 |
2,554 |
$23K |
| 83880 |
|
1,913 |
1,640 |
$21K |
| 84703 |
|
4,706 |
4,043 |
$20K |
| 87420 |
|
975 |
948 |
$19K |
| 76705 |
|
258 |
233 |
$19K |
| 87807 |
|
1,423 |
1,244 |
$18K |
| 88175 |
|
609 |
562 |
$18K |
| 83021 |
|
2,063 |
1,912 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,950 |
4,191 |
$14K |
| 99219 |
|
307 |
196 |
$12K |
| G0379 |
Direct admission of patient for hospital observation care |
91 |
75 |
$12K |
| A9270 |
Non-covered item or service |
24,820 |
7,331 |
$11K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,377 |
4,868 |
$11K |
| 96366 |
|
88 |
50 |
$10K |
| 88305 |
|
210 |
179 |
$10K |
| 85379 |
|
1,936 |
1,687 |
$10K |
| Q3014 |
Telehealth originating site facility fee |
581 |
516 |
$9K |
| 99281 |
|
66 |
61 |
$9K |
| 97110 |
|
285 |
73 |
$9K |
| 82248 |
|
3,143 |
2,791 |
$8K |
| 87040 |
|
1,758 |
845 |
$7K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
205 |
189 |
$7K |
| 87624 |
|
203 |
188 |
$6K |
| 81025 |
|
1,013 |
901 |
$6K |
| 96127 |
|
998 |
971 |
$6K |
| 59025 |
|
112 |
68 |
$6K |
| 85027 |
|
1,435 |
1,169 |
$6K |
| 94760 |
|
561 |
497 |
$5K |
| 99203 |
|
124 |
117 |
$5K |
| 93306 |
|
25 |
25 |
$5K |
| 94640 |
|
222 |
175 |
$4K |
| 80055 |
|
155 |
145 |
$4K |
| 72100 |
|
177 |
148 |
$4K |
| 85730 |
|
2,193 |
1,841 |
$4K |
| 85610 |
|
2,794 |
2,274 |
$3K |
| 74022 |
|
57 |
54 |
$3K |
| 43239 |
|
20 |
13 |
$3K |
| 83036 |
|
484 |
469 |
$3K |
| G0378 |
Hospital observation service, per hour |
86 |
76 |
$3K |
| 80048 |
|
862 |
599 |
$3K |
| 45385 |
|
13 |
12 |
$3K |
| 86703 |
|
210 |
197 |
$3K |
| 72125 |
|
104 |
97 |
$3K |
| 81003 |
|
2,679 |
2,281 |
$3K |
| 86787 |
|
169 |
158 |
$3K |
| 87077 |
|
1,746 |
1,477 |
$2K |
| 82306 |
|
154 |
148 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
708 |
435 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
704 |
515 |
$2K |
| 82607 |
|
312 |
284 |
$2K |
| 99204 |
|
24 |
20 |
$2K |
| 76817 |
|
28 |
24 |
$2K |
| 87186 |
|
836 |
677 |
$2K |
| 99406 |
|
325 |
271 |
$2K |
| 99212 |
|
113 |
108 |
$1K |
| 83735 |
|
470 |
356 |
$1K |
| 99211 |
|
198 |
188 |
$1K |
| 92587 |
|
29 |
26 |
$1K |
| 82803 |
|
406 |
310 |
$1K |
| 80305 |
|
112 |
100 |
$985.91 |
| 72110 |
|
20 |
18 |
$920.30 |
| 99215 |
Prolong outpt/office vis |
35 |
30 |
$913.82 |
| 77067 |
|
13 |
13 |
$690.27 |
| 85018 |
|
207 |
187 |
$637.10 |
| 76816 |
|
15 |
12 |
$633.94 |
| 87176 |
|
510 |
439 |
$600.99 |
| 86592 |
|
131 |
119 |
$580.15 |
| 96376 |
|
137 |
96 |
$496.79 |
| 82950 |
|
90 |
80 |
$456.96 |
| 84702 |
|
46 |
37 |
$444.25 |
| 72050 |
|
17 |
14 |
$310.21 |
| 69210 |
|
15 |
12 |
$268.36 |
| 73560 |
|
53 |
48 |
$250.81 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
411 |
360 |
$249.27 |
| 87071 |
|
15 |
12 |
$236.92 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
804 |
536 |
$231.50 |
| J2704 |
Injection, propofol, 10 mg |
185 |
144 |
$229.09 |
| 82150 |
|
60 |
52 |
$224.66 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
67 |
63 |
$208.76 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
425 |
330 |
$199.19 |
| 94664 |
|
12 |
12 |
$199.15 |
| 72070 |
|
16 |
13 |
$181.76 |
| 36600 |
|
212 |
165 |
$155.56 |
| 83540 |
|
30 |
27 |
$122.86 |
| 90686 |
|
2,342 |
2,179 |
$105.69 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
114 |
92 |
$101.21 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
75 |
66 |
$86.37 |
| 82962 |
|
72 |
48 |
$82.77 |
| 73630 |
|
12 |
12 |
$71.43 |
| 86900 |
|
17 |
15 |
$16.17 |
| 77063 |
|
13 |
13 |
$12.66 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
511 |
306 |
$8.69 |
| 86850 |
|
17 |
14 |
$8.07 |
| 86901 |
|
18 |
15 |
$8.07 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
54 |
49 |
$6.32 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
107 |
77 |
$0.95 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
14 |
13 |
$0.00 |
| 90656 |
|
89 |
89 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
41 |
37 |
$0.00 |
| 76377 |
|
15 |
13 |
$0.00 |
| 91307 |
|
14 |
12 |
$0.00 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
16 |
12 |
$0.00 |
| 90670 |
|
33 |
25 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
20 |
13 |
$0.00 |